NASDAQ:CALA

Calithera Biosciences Stock Signals

etoro logo Buy CALA
*Your capital is at risk
$0.0004
+0.0001 (+33.33%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Calithera Biosciences

General

Signal Type Signal Value Data
Score 0.000 81 days ( -14.29 %
Last Price $0.0004 33.33 %
Performance History
7 Days
$0.0003 $0.0004
33.33%
30 Days
$0.0005 $0.0004
-20.00%
12 Mos
$0.0001 $0.0004
300.00%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 50.68
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0004 - $0.0004
Trend - 3 mos 55.11 % High Width: 124.29 %
Pred. range - 3 mos $0.0004 - $0.0008 Low -5.43 % - 112.12 %
Volume Direction Sell High Volume: 159 · Direction: 0
Pivot Short Buy Very Low Jun 01, 2026 - 15 days
RSI Short Pivot Signal Buy Very Low Jun 18, 2026 - 2 days
Short MA 3 mos Sell Low Jun 11, 2026 - 7 days
Long MA 3 mos Buy Medium Jun 18, 2026 - 2 days
Short/Long MA 3 mos Sell Medium Jun 05, 2026 - 11 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 76.77
Signal Type Signal Value Importance Data
Trend - 12 mos 3.30 % Very High Width: 869.04 %
Pred. range - 12 mos $0.0001 - $0.0011 High -72.87 % - 162.90 %
Short MA 12 mos Buy Very High Jun 18, 2026 - 2 days
Long MA 12 mos Buy Very High Jun 03, 2026 - 13 days
Short/Long MA 12 mos Buy Very High May 13, 2026 - 27 days
Pivot Long Sell Low Nov 28, 2025 - 140 days
RSI Long Pivot Signal Buy Low Jun 18, 2026 - 2 days
Bollinger Buy Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CALITHERA BIOSCIENCES
Calithera Biosciences
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE